+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Anti-nuclear Antibody (ANA) Testing Market 2021-2025- Product Image
Global Anti-nuclear Antibody (ANA) Testing Market 2021-2025- Product Image

Global Anti-nuclear Antibody (ANA) Testing Market 2021-2025

  • ID: 5349658
  • Report
  • May 2021
  • Region: Global
  • TechNavio

FEATURED COMPANIES

  • Abbott Laboratories
  • Abcam Plc
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche Ltd.
  • Immuno Concepts Ltd.
  • Merck KGaA
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The publisher has been monitoring the anti-nuclear antibody (ANA) testing market and it is poised to grow by 362.30 million during 2021-2025, progressing at a CAGR of about 7% during the forecast period. This report on anti-nuclear antibody (ANA) testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing number of autoimmune diseases and discovery of novel biomarkers. In addition, increasing number of autoimmune diseases is anticipated to boost the growth of the market as well.

The anti-nuclear antibody (ANA) testing market analysis includes end-user segment and geographic landscape.

The anti-nuclear antibody (ANA) testing market is segmented as below:

By End-user
  • Hospitals
  • Clinical diagnostic laboratories
By Geographical Landscape
  • North America
  • Europe
  • Asia
  • ROW
This study identifies the advances in laboratory automation platforms as one of the prime reasons driving the anti-nuclear antibody (ANA) testing market growth during the next few years.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

This report on anti-nuclear antibody (ANA) testing market covers the following areas:
  • Anti-nuclear antibody (ANA) testing market sizing
  • Anti-nuclear antibody (ANA) testing market forecast
  • Anti-nuclear antibody (ANA) testing market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading anti-nuclear antibody (ANA) testing market vendors that include Abbott Laboratories, Abcam Plc, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Immuno Concepts Ltd., Merck KGaA, PerkinElmer Inc., Seramun Diagnostica GmbH, Thermo Fisher Scientific Inc., and Trinity Biotech Plc. Also, the anti-nuclear antibody (ANA) testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The publisher's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Abcam Plc
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche Ltd.
  • Immuno Concepts Ltd.
  • Merck KGaA
Executive Summary
  • Market overview
Market Landscape
  • Market ecosystem
  • Value chain analysis
Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025
Five Forces Analysis
  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Market Segmentation by End-user
  • Market segments
  • Comparison by End-user
  • Hospitals - Market size and forecast 2020-2025
  • Clinical diagnostic laboratories - Market size and forecast 2020-2025
  • Market opportunity by End-user
Customer Landscape

Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends
Vendor Landscape
  • Overview
  • Vendor landscape
  • Landscape disruption
Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories
  • Abcam Plc
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche Ltd.
  • Immuno Concepts Ltd.
  • Merck KGaA
  • PerkinElmer Inc.
  • Seramun Diagnostica GmbH
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech Plc
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations
List of Exhibits
  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Key Finding 8
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2020 - 2025 ($ million)
  • Global market: Year-over-year growth 2020 - 2025 (%)
  • Five forces analysis 2020 & 2025
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2020
  • End user - Market share 2020-2025 (%)
  • Comparison by End user
  • Hospitals - Market size and forecast 2020-2025 ($ million)
  • Hospitals - Year-over-year growth 2020-2025 (%)
  • Clinical diagnostic laboratories - Market size and forecast 2020-2025 ($ million)
  • Clinical diagnostic laboratories - Year-over-year growth 2020-2025 (%)
  • Market opportunity by End user
  • Customer landscape
  • Market share by geography 2020-2025 (%)
  • Geographic comparison
  • North America - Market size and forecast 2020-2025 ($ million)
  • North America - Year-over-year growth 2020-2025 (%)
  • Europe - Market size and forecast 2020-2025 ($ million)
  • Europe - Year-over-year growth 2020-2025 (%)
  • APAC - Market size and forecast 2020-2025 ($ million)
  • APAC - Year-over-year growth 2020-2025 (%)
  • ROW - Market size and forecast 2020-2025 ($ million)
  • ROW - Year-over-year growth 2020-2025 (%)
  • Key leading countries
  • Market opportunity by geography ($ million)
  • Impact of drivers and challenges
  • Vendor landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Key customers
  • Abbott Laboratories - Segment focus
  • Abcam Plc - Overview
  • Abcam Plc - Product and service
  • Abcam Plc - Key offerings
  • Abcam Plc - Key customers
  • Abcam Plc - Segment focus
  • Bio-Rad Laboratories Inc. - Overview
  • Bio-Rad Laboratories Inc. - Business segments
  • Bio-Rad Laboratories Inc. - Key offerings
  • Bio-Rad Laboratories Inc. - Key customers
  • Bio-Rad Laboratories Inc. - Segment focus
  • F. Hoffmann-La Roche Ltd. - Overview
  • F. Hoffmann-La Roche Ltd. - Business segments
  • F. Hoffmann-La Roche Ltd. - Key offerings
  • F. Hoffmann-La Roche Ltd. - Key customers
  • F. Hoffmann-La Roche Ltd. - Segment focus
  • Immuno Concepts Ltd. - Overview
  • Immuno Concepts Ltd. - Product and service
  • Immuno Concepts Ltd. - Key offerings
  • Immuno Concepts Ltd. - Key customers
  • Immuno Concepts Ltd. - Segment focus
  • Merck KGaA - Overview
  • Merck KGaA - Business segments
  • Merck KGaA - Key offerings
  • Merck KGaA - Key customers
  • Merck KGaA - Segment focus
  • PerkinElmer Inc. - Overview
  • PerkinElmer Inc. - Business segments
  • PerkinElmer Inc. - Key offerings
  • PerkinElmer Inc. - Key customers
  • PerkinElmer Inc. - Segment focus
  • Seramun Diagnostica GmbH - Overview
  • Seramun Diagnostica GmbH - Product and service
  • Seramun Diagnostica GmbH - Key offerings
  • Seramun Diagnostica GmbH - Key customers
  • Seramun Diagnostica GmbH - Segment focus
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Key customers
  • Thermo Fisher Scientific Inc. - Segment focus
  • Trinity Biotech Plc - Overview
  • Trinity Biotech Plc - Product and service
  • Trinity Biotech Plc - Key offerings
  • Trinity Biotech Plc - Key customers
  • Trinity Biotech Plc - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Abcam Plc
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche Ltd.
  • Immuno Concepts Ltd.
  • Merck KGaA
The publisher recognizes the following companies as the key players in the global anti-nuclear antibody (ANA) testing market: Abbott Laboratories, Abcam Plc, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Immuno Concepts Ltd., Merck KGaA, PerkinElmer Inc., Seramun Diagnostica GmbH, Thermo Fisher Scientific Inc., and Trinity Biotech Plc.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is the advances in laboratory automation platforms.'

According to the report, one of the major drivers for this market is the increasing number of autoimmune diseases.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
  • Abbott Laboratories
  • Abcam Plc
  • Bio-Rad Laboratories Inc.
  • F. Hoffmann-La Roche Ltd.
  • Immuno Concepts Ltd.
  • Merck KGaA
  • PerkinElmer Inc.
  • Seramun Diagnostica GmbH
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech Plc
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll